A vitamin A byproduct could weaken the immune system's cancer-fighting ability, according to new Princeton University ...

The deletion of two cancer genes, CHD1 and MAP3K7, improves how well tumors respond to cancer immunotherapy and could be used ...

The tumor microenvironment (TME) is a metabolically dynamic niche where cancer cells and immune cells interact to influence tumor progression and immune ...

Immunotherapy has transformed cancer care by helping the immune system recognize and destroy tumors. But new research from ...

Colorectal cancer, the abnormal growth of cancerous cells in the large intestine or the rectum, is one of the most common ...

CheckMate 9LA showed a 26% overall survival benefit for metastatic NSCLC patients treated with nivolumab and ipilimumab plus ...

ITI-5000 utilizes nucleic acid vaccine constructs engineered to preferentially deliver tumor-associated antigens (TAAs) to the MHC II compartment via LAMP-1, potentially enhancing antigen presentation ...

Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, potentially opening doors for targeted antibiotic therapies.

Immunotherapy is offering new hope for cancers that once had grim prognoses by harnessing the body's own immune system to ...

Explore the potential of polysaccharide microneedles in cancer immunotherapy for effective drug delivery and immune activation.

In recent years, cancer immunotherapy has transformed the treatment landscape for a wide range of malignancies, offering durable responses and improved survival in select patient populations. However, ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...